Cargando…
A Common Pathogenic Mechanism Linking Type-2 Diabetes and Alzheimer's Disease: Evidence from Animal Models
The failure of large-scale drug trials targeting the amyloidogenic pathway in Alzheimer's disease (AD) is increasing the need to identify a novel pathogenic mechanism. Studies finding a relationship between sporadic AD and type-2 diabetes mellitus (T2DM) are now receiving more attention. The ri...
Autor principal: | Park, Sun Ah |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079154/ https://www.ncbi.nlm.nih.gov/pubmed/21519521 http://dx.doi.org/10.3988/jcn.2011.7.1.10 |
Ejemplares similares
-
Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes
por: Michailidis, Michalis, et al.
Publicado: (2022) -
Diabetes Mellitus Induces Alzheimer’s Disease Pathology: Histopathological Evidence from Animal Models
por: Kimura, Nobuyuki
Publicado: (2016) -
Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
por: Li, Xiaohua, et al.
Publicado: (2015) -
Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets
por: Hamzé, Rim, et al.
Publicado: (2022) -
Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
por: Rojas, Milagros, et al.
Publicado: (2021)